PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 20262 citations

Cytokines and cancer-associated fibroblasts.

View Full Paper
虎杜虎毅 杜Fudan UniversityJLJ-J LiangSun Yat-sen UniversityLDLewei DuanFudan University

Key Points

  • The review aims to categorize the roles of cytokines in relation to cancer-associated fibroblasts within the tumor microenvironment.
  • Systematic categorization of cytokines into major families
  • Evaluation of cytokine roles in CAF activation and tumor malignancy
  • Discussion of therapeutic strategies targeting cytokine networks
  • Cytokines drive interactions between cancer-associated fibroblasts, tumor cells, and immune infiltrates
  • Therapies targeting cytokine signaling show promise for precision oncology
  • Challenges include pleiotropy and redundancy in cytokine functions

Abstract

Cancer-associated fibroblast (CAF) is the dominant stromal component within the tumor microenvironment (TME), driving tumor malignancy through complex cell-to-cell communication, with cytokines serving as the fundamental communication medium. In this review, we systematically categorize cytokines into several major families-including interleukins, chemokines, growth factors, tumor necrosis factors, interferons, colony-stimulating factors, and complement system-to delineate their distinct roles in the reciprocal interactions around CAFs, tumor cells, and immune infiltrates. We explore how cytokines function as upstream signals that guide CAF activation and lineage commitment, as well as downstream effectors secreted by CAFs to promote tumor cell malignancy and reprogram the TME. Furthermore, we evaluate therapeutic strategies that target this network by reprogramming CAF functions through blockade of upstream activators or downstream mediators, and by harnessing CAFs for local cytokine delivery. Finally, we address key challenges impeding clinical translation-arising from the pleiotropy, functional redundancy, compensatory feedback loops and spatiotemporal heterogeneity that characterize cytokine signaling networks, as well as from the inherent limitations of current preclinical models-and we outline a theoretical framework for optimizing cytokine-targeted therapies in precision oncology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

杜 et al. (2026) studied this question.

synapsesocial.com/papers/69faa1eb04f884e66b532aadhttps://doi.org/10.1186/s13045-026-01801-x
Ask AI
Helpful
Bookmark
Share
View Full Paper